Literature DB >> 17389721

Stress chaperones, mortalin, and pex19p mediate 5-aza-2' deoxycytidine-induced senescence of cancer cells by DNA methylation-independent pathway.

Nashi Widodo1, Custer C Deocaris, Kamaljit Kaur, Kamrul Hasan, Tomoko Yaguchi, Kazuhiko Yamasaki, Takashi Sugihara, Tetsuro Ishii, Renu Wadhwa, Sunil C Kaul.   

Abstract

DNA demethylating agents are used to reverse epigenetic silencing of tumor suppressors in cancer therapeutics. Understanding of the molecular and cellular factors involved in DNA demethylation-induced gene desilencing and senescence is still limited. We have tested the involvement of two stress chaperones, Pex19p and mortalin, in 5-Aza-2' deoxycytidine (5AZA-dC; DNA demethylating agent)-induced senescence. We found that the cells overexpressing these chaperones were highly sensitive to 5AZA-dC, and their partial silencing eliminated 5AZA-dC-induced senescence in human osteosarcoma cells. We demonstrate that these chaperones modulate the demethylation and chromatin remodeling-dependent (as accessed by p16(INK4A) expression) and remodeling-independent (such as activation of tumor suppressor p53 pathway) senescence response of cells. Furthermore, we found the direct interactions of 5AZA-dC with these chaperones that may alter their functions. We conclude that both mortalin and Pex19p are important mediators, prognostic indicators, and tailoring tools for 5AZA-dC-induced senescence in cancer cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17389721     DOI: 10.1093/gerona/62.3.246

Source DB:  PubMed          Journal:  J Gerontol A Biol Sci Med Sci        ISSN: 1079-5006            Impact factor:   6.053


  8 in total

Review 1.  Epigenetic alterations in osteosarcoma: promising targets.

Authors:  Binghao Li; Zhaoming Ye
Journal:  Mol Biol Rep       Date:  2014-02-06       Impact factor: 2.316

2.  Structural studies of UBXN2A and mortalin interaction and the putative role of silenced UBXN2A in preventing response to chemotherapy.

Authors:  Sanam Sane; Ammara Abdullah; Morgan E Nelson; Hongmin Wang; Subhash C Chauhan; Samuel S Newton; Khosrow Rezvani
Journal:  Cell Stress Chaperones       Date:  2015-12-04       Impact factor: 3.667

3.  Molecular interactions of Bcl-2 and Bcl-xL with mortalin: identification and functional characterization.

Authors:  Nishant Saxena; Shashank P Katiyar; Ye Liu; Abhinav Grover; Ran Gao; Durai Sundar; Sunil C Kaul; Renu Wadhwa
Journal:  Biosci Rep       Date:  2013-10-16       Impact factor: 3.840

4.  A plant alkaloid, veratridine, potentiates cancer chemosensitivity by UBXN2A-dependent inhibition of an oncoprotein, mortalin-2.

Authors:  Ammara Abdullah; Sanam Sane; Kate A Branick; Jessica L Freeling; Hongmin Wang; Dong Zhang; Khosrow Rezvani
Journal:  Oncotarget       Date:  2015-09-15

5.  DNMT3A and DNMT3B Targeting as an Effective Radiosensitizing Strategy in Embryonal Rhabdomyosarcoma.

Authors:  Simona Camero; Giulia Vitali; Paola Pontecorvi; Simona Ceccarelli; Eleni Anastasiadou; Francesca Cicchetti; Elisabetta Flex; Silvia Pomella; Matteo Cassandri; Rossella Rota; Francesco Marampon; Cinzia Marchese; Amalia Schiavetti; Francesca Megiorni
Journal:  Cells       Date:  2021-10-30       Impact factor: 6.600

6.  Identification of a new member of Mortaparib class of inhibitors that target mortalin and PARP1.

Authors:  Hazna Noor Meidinna; Seyad Shefrin; Anissa Nofita Sari; Huayue Zhang; Jaspreet Kaur Dhanjal; Sunil C Kaul; Durai Sundar; Renu Wadhwa
Journal:  Front Cell Dev Biol       Date:  2022-09-12

7.  The lack of functional DNMT2/TRDMT1 gene modulates cancer cell responses during drug-induced senescence.

Authors:  Dominika Bloniarz; Jagoda Adamczyk-Grochala; Anna Lewinska; Maciej Wnuk
Journal:  Aging (Albany NY)       Date:  2021-06-17       Impact factor: 5.682

Review 8.  Small molecule compounds that induce cellular senescence.

Authors:  Nadezhda V Petrova; Artem K Velichko; Sergey V Razin; Omar L Kantidze
Journal:  Aging Cell       Date:  2016-09-14       Impact factor: 9.304

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.